K Fujihara
Overview
Explore the profile of K Fujihara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
2194
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Whittam D, Karthikeayan V, Gibbons E, Kneen R, Chandratre S, Ciccarelli O, et al.
J Neurol
. 2020 Jul;
267(12):3565-3577.
PMID: 32623595
Introduction: While monophasic and relapsing forms of myelin oligodendrocyte glycoprotein antibody associated disorders (MOGAD) are increasingly diagnosed world-wide, consensus on management is yet to be developed. Objective: To survey the...
2.
Nojima T, Matsubayashi Y, Yoshida A, Suganami H, Abe T, Ishizawa M, et al.
Diabet Med
. 2020 Feb;
37(8):1316-1325.
PMID: 32096571
Aims: To examine the effects of a sodium-glucose co-transporter 2 (SGLT2) inhibitor, tofogliflozin, on resting heart rate by exploring baseline factors that independently influenced changes in the resting heart rate....
3.
Kodama S, Fujihara K, Horikawa C, Harada M, Ishiguro H, Kaneko M, et al.
Obes Rev
. 2018 Oct;
19(12):1621-1629.
PMID: 30270528
Background: Bariatric surgery leads to a higher remission rate for type 2 diabetes mellitus than non-surgical treatment. However, it remains unsolved which surgical procedure is the most efficacious. This network...
4.
Jarius S, Paul F, Aktas O, Asgari N, Dale R, De Seze J, et al.
Nervenarzt
. 2018 Sep;
89(12):1388-1399.
PMID: 30264269
Over the past few years, new-generation cell-based assays have demonstrated a robust association of autoantibodies to full-length human myelin oligodendrocyte glycoprotein (MOG-IgG) with (mostly recurrent) optic neuritis, myelitis and brainstem...
5.
Harada M, Fujihara K, Osawa T, Yamamoto M, Kaneko M, Ishizawa M, et al.
Diabetes Metab
. 2018 Sep;
46(4):331-334.
PMID: 30213710
Aim: To examine the association between treatment-achieved HbA values and incidence of both coronary artery disease (CAD) and severe eye disease with different diabetes treatments. Methods: Associations of treatment-achieved HbA...
6.
Jarius S, Paul F, Aktas O, Asgari N, Dale R, De Seze J, et al.
J Neuroinflammation
. 2018 May;
15(1):134.
PMID: 29724224
Over the past few years, new-generation cell-based assays have demonstrated a robust association of autoantibodies to full-length human myelin oligodendrocyte glycoprotein (MOG-IgG) with (mostly recurrent) optic neuritis, myelitis and brainstem...
7.
Matsubayashi Y, Yoshida A, Suganami H, Ishiguro H, Yamamoto M, Fujihara K, et al.
Diabetes Metab
. 2018 Feb;
44(2):135-142.
PMID: 29395810
Aim: Hepatic insulin clearance (HIC) is important in regulating plasma insulin levels. Diminished HIC causes inappropriate hyperinsulinaemia, and both obesity and fatty liver (FL), which are known to decrease HIC,...
8.
Abe T, Matsubayashi Y, Yoshida A, Suganami H, Nojima T, Osawa T, et al.
Diabetes Metab
. 2017 Nov;
44(2):172-174.
PMID: 29128289
No abstract available.
9.
Nishiyama S, Misu T, Nuriya M, Takano R, Takahashi T, Nakashima I, et al.
Biochem Biophys Rep
. 2017 Nov;
7:45-51.
PMID: 29114578
Background: Neuromyelitis optica (NMO) is an inflammatory disease caused by the aquaporin (AQP)-4-antibody. Pathological studies on NMO have revealed extensive astrocytic damage, as evidenced by the loss of AQP4 and...
10.
Fujihara K, Matsubayashi Y, Yamamoto M, Osawa T, Ishizawa M, Kaneko M, et al.
Diabetes Metab
. 2017 Sep;
43(6):543-546.
PMID: 28918195
Objective: This study aimed to examine the impact of obesity, as defined by body mass index (BMI), and a metabolically unhealthy phenotype on the development of coronary artery disease (CAD)...